Figure 1From: Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabineDose Responses for gemcitabine - The survival fractions are shown for MCF-7cells (A) and MDA-MB-231 cells (B) treated with indicated concentrations of gemcitabine for 24 h (black squares) and 48 h (red circles). IC50 values for 48 h treatment are indicated in the text.Back to article page